default author photo

Gregory J. Dore

University of New South Wales (UNSW) - Kirby Institute

Sydney

Australia

SCHOLARLY PAPERS

11

DOWNLOADS

2,003

TOTAL CITATIONS

8

Scholarly Papers (11)

1.

Vaccine Apartheid: A Human Rights Analysis of COVID-19 Vaccine Inequity (Initial SSRN Version from 2021)

Number of pages: 37 Posted: 30 Jun 2021 Last Revised: 29 Sep 2022
Sarah Joseph and Gregory J. Dore
Griffith University and University of New South Wales (UNSW) - Kirby Institute
Downloads 1,190 (44,235)
Citation 5

Abstract:

Loading...

COVID, COVID-19, vaccination, vaccines, vaccine inequity, human rights, international human rights law, TRIPS, TRIPS waiver, intellectual property

2.

Vaccine Apartheid: A Human Rights Analysis of COVID-19 Vaccine Inequity

Journal of Transnational Law & Policy, Forthcoming
Number of pages: 46 Posted: 30 Sep 2022
Sarah Joseph and Gregory J. Dore
Griffith University and University of New South Wales (UNSW) - Kirby Institute
Downloads 174 (433,279)

Abstract:

Loading...

international human rights law, COVID-19, vaccines, human rights, extraterritoriality, global justice, TRIPS, intellectual property

Optimizing Point-of-Care Testing Strategies for Diagnosis and Treatment of Hepatitis C Virus Infection in Australia: A Model-Based Cost-Effectiveness Analysis

Number of pages: 33 Posted: 17 Nov 2022
University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute and University of New South Wales (UNSW) - Kirby Institute
Downloads 87 (767,205)

Abstract:

Loading...

HCV, health economics, modelling, antibody testing, RNA testing

Optimizing Point-of-Care Testing Strategies for Diagnosis and Treatment of Hepatitis C Virus Infection in Australia: A Model-Based Cost-Effectiveness Analysis

Number of pages: 33 Posted: 21 Dec 2022
University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute and University of New South Wales (UNSW) - Kirby Institute
Downloads 76 (840,816)

Abstract:

Loading...

HCV, health economics, modelling, antibody testing, RNA testing

4.

Global, Regional, and Country-Level Coverage of Testing and Treatment for HIV and Hepatitis C Infection Among People Who Inject Drugs: A Systematic Review

Number of pages: 33 Posted: 29 Mar 2023
University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - National Drug and Alcohol Research Centre (NDARC), University of New South Wales (UNSW) - National Drug and Alcohol Research Centre (NDARC), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - National Drug and Alcohol Research Centre (NDARC), University of New South Wales (UNSW) - National Drug and Alcohol Research Centre (NDARC), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - National Drug and Alcohol Research Centre (NDARC), University of New South Wales (UNSW) - National Drug and Alcohol Research Centre (NDARC), University of New South Wales (UNSW) - National Drug and Alcohol Research Centre (NDARC), University of Bristol - Department of Population Health Sciences, University of New South Wales (UNSW) - National Drug and Alcohol Research Centre (NDARC), University of Bristol - Department of Population Health Sciences, University of New South Wales (UNSW) - Kirby Institute, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), University of New South Wales (UNSW) - National Drug and Alcohol Research Centre (NDARC) and University of New South Wales (UNSW) - Kirby Institute
Downloads 98 (699,467)

Abstract:

Loading...

HCV, human immunodeficiency virus, clinical care, coverage, substance use

5.

Hepatitis C Reinfection Risk Following Successful Therapy Among People Living with HIV: A Global Systematic Review, Meta-Analysis, and Meta-Regression

Number of pages: 34 Posted: 08 Nov 2021
University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of British Columbia (UBC) - School of Population and Public Health, Medical University of Vienna - Division of Gastroenterology and Hepatology, Bonn University Hospital - Department of Medicine I, University of Bonn - Department of Internal Medicine I, University of California, San Diego (UCSD), University Hospital of Henri-Mondor, APHP - Hepatology Department, National Taiwan University Hospital (Yunlin Branch), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute and University of New South Wales (UNSW) - Kirby Institute
Downloads 75 (837,727)
Citation 2

Abstract:

Loading...

HIV, People living with HIV, Hepatitis C Virus, HCV, Reinfection, recurrent viremia, Men who have sex with men, People who inject drugs, direct-acting antivirals

6.

Reduced Hepatitis C Incidence Associated with Rapid Treatment Scale-Up in Australian Prisons: Treatment-as-Prevention in the SToP-C Study

Number of pages: 47 Posted: 16 Oct 2020
University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of Bristol - Population Health Sciences, University of Bristol - Population Health Sciences, Assembly Biosciences, Gilead Sciences, Inc., University of New South Wales (UNSW) - Centre for Social Research in Health, University of New South Wales (UNSW) - Centre for Big Data Research in Health, Corrective Services NSW, NSW Health - Justice Health and Forensic Mental Health Network, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute and Independent
Downloads 67 (899,324)
Citation 1

Abstract:

Loading...

HCV, direct-acting antivirals, correctional setting, injecting drug use, clinical trial

7.

Hepatitis C Virus Transmission Dynamics in a Global Cohort of Men Who Have Sex with Men with Recently Acquired Infection

Number of pages: 19 Posted: 01 Jun 2022
University of Amsterdam - Amsterdam University Medical Centers, University of New South Wales (UNSW) - Kirby Institute, University of Bonn - Department of Internal Medicine I, University of New South Wales (UNSW) - Kirby Institute, Government of the United Kingdom - Royal Free London NHS Foundation Trust, University of New South Wales (UNSW) - Kirby Institute, University of Bern - Department of Infectious Diseases, Burnet Institute, University of Bern - Department of Infectious Diseases, University of Bonn - Department of Internal Medicine I, University of Amsterdam - Department of Medical Microbiology & Infection Prevention, Viral Hepatitis Care Network (VIRCAN), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of New South Wales (UNSW) - Kirby Institute, Burnet Institute, University of New South Wales (UNSW) - Kirby Institute, University of Amsterdam - Department of Medical Microbiology & Infection Prevention, University of Amsterdam - Department of Infectious Diseases and Independent
Downloads 58 (980,173)

Abstract:

Loading...

Hepatitis C virus, MSM, transmission, genomic epidemiology

8.

Moving Towards HCV Elimination Among People Living with HIV in Australia: Analysis of the CEASE Prospective Cohort Study

Number of pages: 36 Posted: 22 Oct 2018
University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, Government of New South Wales - Kirketon Road Centre, East Sydney Doctors, Government of New South Wales - The Albion Centre, Taylor Square Private Clinic, Holdsworth House Medical Practice, Burnet Institute, Royal Adelaide Hospital, Brisbane Sexual Health Clinic, Dr. N Doong, Government of New South Wales - Blue Mountains Sexual Health and HIV Clinic, Burnet Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute and University of New South Wales (UNSW) - Kirby Institute
Downloads 54 (1,031,043)

Abstract:

Loading...

HCV; HIV; Elimination; Gay and Bisexual Men; Treatment as Prevention

9.

Hepatocellular Carcinoma Incidence After Hepatitis C Cure Among Patients With Advanced Fibrosis or Cirrhosis: A Systematic Review and Meta-Analysis

Number of pages: 30 Posted: 26 Oct 2021
University of New South Wales (UNSW) - St Vincent's Clinical School, University of New South Wales (UNSW), University of New South Wales (UNSW), University of New South Wales (UNSW) - Kirby Institute and University of New South Wales (UNSW) - St Vincent's Clinical School
Downloads 47 (1,097,529)

Abstract:

Loading...

Hepatitis C, fibrosis, cirrhosis, sustained virologic response, direct-acting antiviral, hepatocellular carcinoma, systematic review, meta-regression

10.

Australia on Track to Achieve Who HCV Elimination Targets Following Rapid Initial DAA Treatment Uptake: A Modelling Study

Number of pages: 27 Posted: 06 Aug 2018
University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, Government of New South Wales - Ministry of Health, Centre for Disease Analysis, Center for Disease Analysis Foundation and University of New South Wales (UNSW) - Kirby Institute
Downloads 44 (1,145,425)

Abstract:

Loading...

Hepatitis C virus, direct-acting antiviral therapy, modeling projections, HCV elimination, high-income setting, liver-related mortality, treatment scenarios

11.

Validation of Dried Blood Spots for Detection of SARS-CoV-2 Antibodies Post Infection to Support Responses in Settings of Public Health Importance

Number of pages: 27 Posted: 24 Mar 2022
University of New South Wales (UNSW) - St Vincent’s Centre for Applied Medical Research, University of New South Wales (UNSW) - St Vincent’s Centre for Applied Medical Research, University of New South Wales (UNSW) - Kirby Institute, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, St. Vincent's Hospital, University of New South Wales (UNSW) - Kirby Institute and affiliation not provided to SSRN
Downloads 33 (1,277,121)

Abstract:

Loading...

Dried blood spots, DBS, SARS-COV-2, COVID-19, surveillance, Diagnostics